GENEVA, Oct. 5 -- NOVARTIS AG filed a patent application (IB2026/052976) for “DOUBLE STRANDED RNAi AGENTS, COMPOSITIONS AND METHODS OF USE”. With publication no. WO/2026/202809, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C12N 15/113
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....